Ultragenyx Pharmaceutical
RARE
#3686
Rank
A$5.25 B
Marketcap
A$54.44
Share price
0.08%
Change (1 day)
-25.98%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: A$5.25 Billion

As of December 2025 Ultragenyx Pharmaceutical has a market cap of A$5.25 Billion. This makes Ultragenyx Pharmaceutical the world's 3686th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025A$5.25 B-18.52%
2024A$6.44 B11.85%
2023A$5.76 B20.76%
2022A$4.77 B-39.63%
2021A$7.90 B-33.62%
2020A$11.91 B237.56%
2019A$3.52 B12.4%
2018A$3.13 B24.07%
2017A$2.53 B-36.52%
2016A$3.98 B-33.44%
2015A$5.98 B249.69%
2014A$1.71 B

End of Day market cap according to different sources

On Dec 12th, 2025 the market cap of Ultragenyx Pharmaceutical was reported to be:

A$5.25 Billion
by Nasdaq info icon info icon
A$5.25 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioMarin Pharmaceutical
BMRN
A$15.39 B 193.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$4.89 B-6.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$1.37 B-73.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
A$0.70 B-86.48%๐Ÿ‡บ๐Ÿ‡ธ USA